文献速递肝病消化内镜

经颈静脉肝内门体分流术对肝硬化和严重门静脉高压患者体成分的影响:一项基于CT的大型回顾性监测研究

Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance.
PubMed 文献 · Aliment Pharmacol Ther · 2020-09-15

该研究回顾性纳入2011至2017年在本中心因严重门静脉高压接受经颈静脉肝内门体分流术(TIPSS)的179例肝硬化患者,在基线、1-3个月和6个月进行基于CT的监测。结果显示,肌肉减少症与6个月死亡独立相关,TIPSS置入后骨骼肌指标和皮下脂肪面积增加,而内脏脂肪面积在基线至1-3个月下降。

要点

  • MELD评分(HR 1.14,95%CI 1.08-1.20)和基于CT的肌肉减少症(HR 0.86,95%CI 0.79-0.96)与6个月死亡独立相关。
  • TIPSS置入后TPMT/身高从基线19 mm/m升至1-3个月19.6 mm/m(P=0.004)和6个月21.1 mm/m(P<0.0001)。
  • 皮下脂肪面积从基线183.4 cm²升至1-3个月193 cm²和6个月229.8 cm²(均P<0.0001),内脏脂肪面积仅基线至1-3个月下降。

核心结论

  • 肌肉减少症与6个月结局独立相关,TIPSS置入后肌肉减少症改善,同时皮下脂肪与内脏脂肪呈相反变化。
  • TIPSS不仅治疗门静脉高压,还改善体成分。

研究设计与样本

  • 回顾性纳入2011至2017年在本中心因严重门静脉高压接受TIPSS置入的179例肝硬化患者。
  • 在基线、1-3个月(M1-M3)和6个月(M6)进行基于CT扫描的监测。

主要发现

  • 中位MELD评分为11.4(8.8-15.1),Child-Pugh评分为8(7-9)。
  • 多因素分析中仅MELD评分(HR 1.14,95%CI 1.08-1.20)和脐水平右侧腰大肌厚度/身高评估的肌肉减少症(HR 0.86,95%CI 0.79-0.96)与6个月死亡独立相关。
  • TIPSS置入后TPMT/身高从基线19 mm/m升至M1-M3 19.6 mm/m(P=0.004)和M6 21.1 mm/m(P<0.0001),其改善及程度取决于TIPSS的影像学通畅性和功能障碍。
  • 皮下脂肪面积从183.4 cm²分别增至193 cm²(P<0.0001)和229.8 cm²(P<0.0001)。
  • 内脏脂肪面积从基线至M1-M3下降(163.5 cm²至140.5 cm²,P<0.0001),但M1-M3至M6无变化(140.5 cm²至141.2 cm²,P=0.9);皮下脂肪面积和内脏脂肪面积似乎不受TIPSS影像学通畅性和功能障碍影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Body composition may be modified after improvement of portal hypertension (PHT) by transjugular intrahepatic portosystemic shunt (TIPSS) insertion. AIMS: To evaluate changes in body composition following TIPSS placement, their relationship with radiological TIPSS patency and function, and the predictive value of these parameters METHODS: We retrospectively included 179 patients with cirrhosis who underwent TIPSS placement in our centre for severe PHT from 2011 to 2017. CT scan-based surveillance was performed at baseline, 1-3 (M1-M3) and 6 months (M6). RESULTS: The median model for end-stage liver disease (MELD) score was 11.4 (8.8-15.1) and Child-Pugh score 8 (7-9). Only the MELD score (HR 1.14, 95% CI 1.08-1.20) and sarcopenia assessed by transversal right psoas muscle thickness at the umbilical level/height (TPMPT/height) (HR 0.86, 95% CI 0.79-0.96) were independently associated with 6-month mortality on multivariate analysis. After TIPSS insertion, TPMT/height increased from 19 mm/m (baseline) to 19.6 mm/m (M1-M3, P = 0.004) and 21.1 mm/m (M6, P < 0.0001). The improvement and its extent were dependent on the radiological patency and dysfunction of TIPSS. Subcutaneous fat surface (SCFS) increased from 183.4 to 193 cm2 (P < 0.0001) and 229.8 cm2 (P < 0.0001), respectively. We observed a decrease in visceral fat surface (VFS) between baseline and M1-M3 (163.5-140.5 cm2 [P < 0.0001]), but not between M1-M3 and M6 (140.5-141.2 cm2 [P = 0.9]). SCFS and VFS did not seem to be modified by radiological TIPSS patency and dysfunction. CONCLUSIONS: Sarcopenia is independently associated with 6-month outcome and improves after TIPSS placement, together with an inverse evolution of subcutaneous and visceral fat. TIPSS not only treats PHT but also improves body composition.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Artru F, Miquet X, Azahaf M, et al. Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance. Aliment Pharmacol Ther. 2020. PMID: 32931618. doi:10.1111/apt.16080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。